In another study, TPX2 expression was found to be reduced in HCC-infiltrating CD8 + T cells, and downregulated TPX2 restricted the anticancer effect of CD8 + T cells in HCC, whereas such antitumor activity was enhanced by TPX2 overexpression (Wang et al. 2022a). Here, CD8A is linked to hepatocellular carcinoma.